{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "61958-1803",
      "generic_name": "ledipasvir and sofosbuvir",
      "labeler_name": "Gilead Sciences, Inc",
      "brand_name": "Harvoni",
      "active_ingredients": [
        {
          "name": "LEDIPASVIR",
          "strength": "45 mg/1"
        },
        {
          "name": "SOFOSBUVIR",
          "strength": "200 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "61958-1803-1",
          "description": "28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-1803-1)",
          "marketing_start_date": "20190828",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Gilead Sciences, Inc"
        ],
        "rxcui": [
          "1591943",
          "1591949",
          "2203895",
          "2203897",
          "2204100",
          "2204102",
          "2204103",
          "2204104"
        ],
        "spl_set_id": [
          "f4ec77e4-bae8-4db0-b3d5-bde09c5fa075"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000191256",
          "N0000185503",
          "N0000190113",
          "N0000191493",
          "N0000191258"
        ],
        "pharm_class_epc": [
          "Hepatitis C Virus NS5A Inhibitor [EPC]",
          "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]",
          "RNA Replicase Inhibitors [MoA]"
        ],
        "unii": [
          "013TE6E4WV",
          "WJ6CA3ZU8B"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "6fc15183-879a-4402-af66-edf57754e31f",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20190828",
      "product_id": "61958-1803_6fc15183-879a-4402-af66-edf57754e31f",
      "application_number": "NDA205834",
      "brand_name_base": "Harvoni",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Hepatitis C Virus NS5A Inhibitor [EPC]",
        "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]",
        "P-Glycoprotein Inhibitors [MoA]",
        "RNA Replicase Inhibitors [MoA]"
      ]
    }
  ]
}